A portion of an earlier prototype
Through successful clinical trials, NeuroleapOne (aka Win3 system) would be evidence-based and function across various discipline, e.g. special education, speech and language pathology, psychology, occupational therapy, etc.
Our system is adaptive and could be customized to fit each individual’s conditions, in particular, to overcome challenges associated with fine motor skills and essential language skills.
It is anticipated that NeuroleapOne will initially be adopted in 105,000 schools and later 225,000 healthcare institutions in the US.
Product details will be announced upon its final release. Currently, a small software portion of the WIN3 System, called SLP-Screener2: Comprehensive Language&Articulation is available for download on iTunes. See below link for more info.
Thank you all for the valuable feedback. We are working on a different but similar app, which is projected to be released in Q2 of 2018.
For details regarding our system and investment opportunity, please contact us at firstname.lastname@example.org
- New technology developments has made it economically feasible
- Recent tragic events have raised the public awareness of the consequences of ignoring psychological issues in youth and the financial cost on the society.
To serve specialists through innovative tools and proven methodologies, so that every child’s path to self-sufficiency and independence is better supported and accelerated.
What Drives Us:
Helping overcome the individual inabilities to move, learn and communicate freely is our fundamental motivation
Neuro Leap Corp.
99 Wilson Ave.
San Jose, CA 95126 USA
All contents © Copyright 2014-2017 Neuro Leap Corp. All rights reserved.